<p><strong>Pediatric use</strong>: The safety and effectiveness of Erlotinib in pediatric patients have not been established.<br />
<br />
<strong>Geriatric use</strong>: No overall differences in safety or efficacy were observed between subjects 65 years and older and those younger than 65.</p>